đź’° Dyslexia is not just an educational challenge—it has become a multi-billion US dollar per annum business. Every year, vast sums are poured into research, therapy programs, brain imaging, pharmaceuticals, tuition, and salaries for professionals across countless organizations. With so much money at stake, it is hardly surprising that dyslexia is often portrayed as a disease—something that can only be “treated” or “cured” through expensive interventions.














